We are live on ! Find out more
NHC icon

National Healthcare

103 hedge funds and large institutions have $397M invested in National Healthcare in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

316% more call options, than puts

Call options by funds: $8.99M | Put options by funds: $2.16M

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

3% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 34

1% more funds holding

Funds holding: 102103 (+1)

0.12% less ownership

Funds ownership: 36.77%36.65% (-0.12%)

6% less capital invested

Capital invested by funds: $422M → $397M (-$25.6M)

Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
2.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
35
Reduced
34
Closed
5
Calls
$8.99M
Puts
$2.16M
Net Calls
+$6.83M
Net Calls Change
+$2.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$61.9M +$3.93M +53,073 +7%
BlackRock
2
BlackRock
New York
$51.5M +$53.2M +719,182 +25,954%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$35.8M +$1.73M +23,411 +5%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$34.3M -$1.27M -17,190 -3%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$27M -$319K -4,304 -1%
Renaissance Technologies
6
Renaissance Technologies
New York
$25.6M +$2.26M +30,526 +9%
State Street
7
State Street
Massachusetts
$19M +$1.47M +19,872 +8%
Northern Trust
8
Northern Trust
Illinois
$15.7M +$1.41M +19,022 +9%
BBHC
9
Brown Brothers Harriman & Co
New York
$10.7M
Bank of New York Mellon
10
Bank of New York Mellon
New York
$9.33M +$500K +6,760 +5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$8.28M +$295K +3,992 +4%
Franklin Resources
12
Franklin Resources
California
$7.49M
ProShare Advisors
13
ProShare Advisors
Maryland
$6.97M +$1.07M +14,469 +17%
Thrivent Financial for Lutherans
14
Thrivent Financial for Lutherans
Minnesota
$5.83M
Bessemer Group
15
Bessemer Group
New Jersey
$4.48M +$3.48M +46,991 +297%
SB
16
Suntrust Banks
Georgia
$3.93M -$113K -1,533 -3%
Russell Investments Group
17
Russell Investments Group
United Kingdom
$3.93M -$165K -2,226 -4%
LSV Asset Management
18
LSV Asset Management
Illinois
$3.45M -$2.86M -38,677 -44%
Charles Schwab
19
Charles Schwab
California
$3.17M +$151K +2,046 +5%
MAM
20
Martingale Asset Management
Massachusetts
$2.82M +$66.6K +900 +2%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$2.8M -$4.02M -54,290 -58%
Norges Bank
22
Norges Bank
Norway
$2.7M -$1.14M -15,437 -29%
Prudential Financial
23
Prudential Financial
New Jersey
$2.37M -$128K -1,730 -5%
TCIM
24
TIAA CREF Investment Management
New York
$2.16M -$551K -7,448 -20%
First Trust Advisors
25
First Trust Advisors
Illinois
$1.98M +$152K +2,055 +8%

NHC Hedge Fund Activity: Q1 2017 in Review

103 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q1 2017, worth a combined $397M — down 6.1% from $422M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NHC positions and 5 closed out — a net gain of 6 holders — while 35 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $53.2M. The largest seller was James Investment Research, cutting an estimated $7.56M.

  • 103 institutional investors held National Healthcare (NHC) as of Q1 2017, up from 102 in Q4 2016.
  • Funds reported $397M of National Healthcare stock for Q1 2017, down 6.1% quarter-over-quarter.
  • 11 funds opened new National Healthcare positions in Q1 2017 and 5 closed out, a net change of +6 holders.
  • The largest National Healthcare buyer in Q1 2017 was BlackRock, an estimated $53.2M added.
  • The largest National Healthcare seller in Q1 2017 was James Investment Research, an estimated $7.56M sold.

Based on aggregated 13F filings for Q1 2017.